Princen HMG - Search Results

1

Atorvastatin accelerates clearance of lipoprotein remnants generated by activated brown fat to further reduce hypercholesterolemia and atherosclerosis.

Hoeke G, Wang Y, van Dam AD, Mol IM, Gart E, Klop HG, van den Berg SM, Pieterman EH, Princen HMG, Groen AK, Rensen PCN, Berbée JFP, Boon MR. Hoeke G, et al. Among authors: princen hmg. Atherosclerosis. 2017 Dec;267:116-126. doi: 10.1016/j.atherosclerosis.2017.10.030. Epub 2017 Oct 26. Atherosclerosis. 2017. PMID: 29121499

2

Apolipoprotein E polymorphism affects plasma levels of lipoprotein(a).

de Knijff P, Kaptein A, Boomsma D, Princen HM, Frants RR, Havekes LM. de Knijff P, et al. Atherosclerosis. 1991 Oct;90(2-3):169-74. doi: 10.1016/0021-9150(91)90111-f. Atherosclerosis. 1991. PMID: 1836947

3

Lipoprotein(a): relation to other risk factors and genetic heritability. Results from a Dutch parent-twin study.

Boomsma DI, Kaptein A, Kempen HJ, Gevers Leuven JA, Princen HM. Boomsma DI, et al. Atherosclerosis. 1993 Feb;99(1):23-33. doi: 10.1016/0021-9150(93)90047-x. Atherosclerosis. 1993. PMID: 8461057

4

Reduced plasma cholesterol and increased fecal sterol loss in multidrug resistance gene 2 P-glycoprotein-deficient mice.

Voshol PJ, Havinga R, Wolters H, Ottenhoff R, Princen HM, Oude Elferink RP, Groen AK, Kuipers F. Voshol PJ, et al. Gastroenterology. 1998 May;114(5):1024-34. doi: 10.1016/s0016-5085(98)70323-3. Gastroenterology. 1998. PMID: 9558293

5

Effects of fenofibrate on hyperlipidemia and postprandial triglyceride metabolism in human apolipoprotein C1 transgenic mice.

Jong MC, Dahlmans VE, Princen HM, Hofker MH, Havekes LM. Jong MC, et al. Atherosclerosis. 1998 Dec;141 Suppl 1:S77-80. doi: 10.1016/s0021-9150(98)00222-6. Atherosclerosis. 1998. PMID: 9888647

6

Dietary cholesterol does not normalize low plasma cholesterol levels but induces hyperbilirubinemia and hypercholanemia in Mdr2 P-glycoprotein-deficient mice.

Voshol PJ, Koopen NR, de Vree JM, Havinga R, Princen HM, Elferink RP, Groen AK, Kuipers F. Voshol PJ, et al. J Hepatol. 2001 Feb;34(2):202-9. doi: 10.1016/s0168-8278(00)00021-0. J Hepatol. 2001. PMID: 11281547

7

Dietary vegetable oil and wood derived plant stanol esters reduce atherosclerotic lesion size and severity in apoE*3-Leiden transgenic mice.

Volger OL, Mensink RP, Plat J, Hornstra G, Havekes LM, Princen HM. Volger OL, et al. Atherosclerosis. 2001 Aug;157(2):375-81. doi: 10.1016/s0021-9150(00)00750-4. Atherosclerosis. 2001. PMID: 11472737

8

Raman spectroscopic investigation of atorvastatin, amlodipine, and both on atherosclerotic plaque development in APOE*3 Leiden transgenic mice.

van de Poll SW, Delsing DJ, Jukema JW, Princen HM, Havekes LM, Puppels GJ, van der Laarse A. van de Poll SW, et al. Atherosclerosis. 2002 Sep;164(1):65-71. doi: 10.1016/s0021-9150(02)00055-2. Atherosclerosis. 2002. PMID: 12119194

9

Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus.

van de Ree MA, Huisman MV, Princen HM, Meinders AE, Kluft C; DALI-Study Group. van de Ree MA, et al. Atherosclerosis. 2003 Jan;166(1):129-35. doi: 10.1016/s0021-9150(02)00316-7. Atherosclerosis. 2003. PMID: 12482559 Clinical Trial.

10

Differential effects of amlodipine and atorvastatin treatment and their combination on atherosclerosis in ApoE*3-Leiden transgenic mice.

Delsing DJ, Jukema JW, van de Wiel MA, Emeis JJ, van der Laarse A, Havekes LM, Princen HM. Delsing DJ, et al. J Cardiovasc Pharmacol. 2003 Jul;42(1):63-70. doi: 10.1097/00005344-200307000-00010. J Cardiovasc Pharmacol. 2003. PMID: 12827028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page